BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15634799)

  • 1. Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform.
    Von Leoprechting A; Kumpf R; Menzel S; Reulle D; Griebel R; Valler MJ; Büttner FH
    J Biomol Screen; 2004 Dec; 9(8):719-25. PubMed ID: 15634799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AlphaScreen-based characterization of the bifunctional kinase/RNase IRE1alpha: a novel and atypical drug target.
    Bouchecareilh M; Caruso ME; Roby P; Parent S; Rouleau N; Taouji S; Pluquet O; Bossé R; Moenner M; Chevet E
    J Biomol Screen; 2010 Apr; 15(4):406-17. PubMed ID: 20237204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-effective solution to reduce dead volume of a standard dispenser system by a factor of 5.
    Bergsdorf C; Gewiese N; Stolz A; Mann R; Parczyk K; Bömer U
    J Biomol Screen; 2006 Jun; 11(4):407-12. PubMed ID: 16490776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Miniaturization of intracellular calcium functional assays to 1536-well plate format using a fluorometric imaging plate reader.
    Hodder P; Mull R; Cassaday J; Berry K; Strulovici B
    J Biomol Screen; 2004 Aug; 9(5):417-26. PubMed ID: 15296641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology.
    Perrin D; Frémaux C; Scheer A
    J Biomol Screen; 2006 Jun; 11(4):359-68. PubMed ID: 16751332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors.
    Hubert CL; Sherling SE; Johnston PA; Stancato LF
    J Biomol Screen; 2003 Aug; 8(4):399-409. PubMed ID: 14567792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miniaturized receptor binding assays: complications arising from ligand depletion.
    Carter CM; Leighton-Davies JR; Charlton SJ
    J Biomol Screen; 2007 Mar; 12(2):255-66. PubMed ID: 17259589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II).
    Schröter T; Minond D; Weiser A; Dao C; Habel J; Spicer T; Chase P; Baillargeon P; Scampavia L; Schürer S; Chung C; Mader C; Southern M; Tsinoremas N; LoGrasso P; Hodder P
    J Biomol Screen; 2008 Jan; 13(1):17-28. PubMed ID: 18227223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of homogeneous 384-well high-throughput screening assays for Abeta1-40 and Abeta1-42 using AlphaScreen technology.
    Szekeres PG; Leong K; Day TA; Kingston AE; Karran EH
    J Biomol Screen; 2008 Feb; 13(2):101-11. PubMed ID: 18216395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two simple and generic antibody-independent kinase assays: comparison of a bioluminescent and a microfluidic assay format.
    Pommereau A; Pap E; Kannt A
    J Biomol Screen; 2004 Aug; 9(5):409-16. PubMed ID: 15296640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A homogeneous 384-well high-throughput binding assay for a TNF receptor using alphascreen technology.
    Wilson J; Rossi CP; Carboni S; Fremaux C; Perrin D; Soto C; Kosco-Vilbois M; Scheer A
    J Biomol Screen; 2003 Oct; 8(5):522-32. PubMed ID: 14567779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further comparison of primary hit identification by different assay technologies and effects of assay measurement variability.
    Wu X; Sills MA; Zhang JH
    J Biomol Screen; 2005 Sep; 10(6):581-9. PubMed ID: 16103421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated high throughput screening for serine kinase inhibitors using a LEADseeker scintillation proximity assay in the 1536-well format.
    Sorg G; Schubert HD; Büttner FH; Heilker R
    J Biomol Screen; 2002 Feb; 7(1):11-9. PubMed ID: 11897051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profiling of chemokine receptor-directed compounds using high-content screening.
    Haasen D; Merk S; Seither P; Martyres D; Hobbie S; Heilker R
    J Biomol Screen; 2008 Jan; 13(1):40-53. PubMed ID: 18227225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening.
    Gilchrist MA; Cacace A; Harden DG
    J Biomol Screen; 2008 Jul; 13(6):486-93. PubMed ID: 18566482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput biochemical kinase selectivity assays: panel development and screening applications.
    Card A; Caldwell C; Min H; Lokchander B; Hualin Xi ; Sciabola S; Kamath AV; Clugston SL; Tschantz WR; Leyu Wang ; Moshinsky DJ
    J Biomol Screen; 2009 Jan; 14(1):31-42. PubMed ID: 19073965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors.
    Chopra P; Nanda K; Chatterjee M; Bajpai M; Dastidar SG; Ray A
    Anal Biochem; 2008 Sep; 380(1):143-5. PubMed ID: 18570885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists.
    Wu X; Glickman JF; Bowen BR; Sills MA
    J Biomol Screen; 2003 Aug; 8(4):381-92. PubMed ID: 14567790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staurosporine-based binding assay for testing the affinity of compounds to protein kinases.
    Iyer GH; Taslimi P; Pazhanisamy S
    Anal Biochem; 2008 Feb; 373(2):197-206. PubMed ID: 18047825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.